Core C: B Cell Core
Core C: B Cell Core
批准号:
10731279
负责人:
Kristina De Paris
金额:
$26.78万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2028-03-31
关键词:
AdultAntibodiesAntibody AvidityAntibody RepertoireAntibody ResponseAntigensAutologousAvidityB-Cell Antigen ReceptorB-Cell DevelopmentB-LymphocytesB-cell receptor repertoire sequencingBar CodesBindingBiological AssayBiometryBone MarrowCell LineageCellsCollaborationsComputer AnalysisDataDevelopmentDoseEngineeringEnvironmentEnzyme-Linked Immunosorbent AssayEpitopesEvolutionFlow CytometryFutureGenerationsGoalsHIVHIV vaccineHIV-1ImmuneImmune responseImmune systemImmunityImmunizationInfantInfectionLaboratoriesLeadLifeLymphoid TissueMacacaMacaca mulattaMediatingMedicineMessenger RNAMolecular ProfilingMonoclonal AntibodiesNatural ImmunityNaturePhenotypePlasmaPlasma CellsPredispositionProcessProteomicsRegimenReproducibilityResourcesRunningSerumSortingSpecificitySurface Plasmon ResonanceTechnologyTimeVaccinatedVaccinationVaccine DesignVaccineeVaccinesVirusWorkautoreactivityexperiencegenetic signaturegenomic platforminnovationlymph nodesmicrobialmicrobiomemicroorganism interactionneutralizing antibodynext generation sequencingnonhuman primateprogramsresponsesingle-cell RNA sequencingtime usetooltranscriptomicstransmission processvaccine evaluationvaccine immunogenicityvaccine strategy
中文摘要
抽象B细胞核心
婴儿中bNAbs的早期发展提示在抗体产生中可能存在不同的机制
由于婴儿免疫系统的高度动态性质,它具有广泛性。此外,我们观察到了启发式
种系靶向HIV环境SOSIP免疫对幼年恒河猴bNAb前体的影响。我们
假设使用种系靶向HIV env SOSIP免疫原诱导bNab前体B细胞
需要特定的先天和微生物相互作用,这些作用是可以修改的,以增强未来的艾滋病毒疫苗战略,
尤其是在早期生活中。在这种情况下,我们提出了一个B细胞核心,它将执行深入的量化和
婴儿BG505 SOSIPGT1.1免疫后血浆和B细胞反应的特征
通过i)多克隆的功能活性、亲和力和靶表位的量化
血浆抗体反应(AIM 1)和抗原特异性B细胞分析(AIM)的单细胞RNA测序
2)评估疫苗诱导的HIV bNAb前体的进化,并将这些反应与先天的
免疫(项目1)和微生物相互作用(项目2)。为了实现这一目标,B细胞核心将抽出
关于B细胞在抗体和B细胞反应表征方面的丰富经验和独特资源
阿姆斯特丹大学医学中心的核心领导者Marit van Gils博士和威尔·康奈尔医学公司的Sallie Permar博士。
英文摘要
ABSTRACT – B Cell Core
Early development of bNAbs in infants suggest potentially distinct mechanisms in the generation of antibody
breadth due to the highly dynamic nature of the infant immune system. Moreover, we have observed elicitation
of bNAb precursors in infant rhesus monkeys with germline-targeting HIV Env SOSIP immunization. We
hypothesize that induction of bnAb precursor B cells using germline-targeting HIV Env SOSIP immunogens
requires specific innate and microbial interactions which are modifiable to enhance future HIV vaccine strategies,
particularly in early life. In this context, we propose a B Cell Core that will perform in-depth quantification and
characterization of the plasma and B cell responses after BG505 SOSIP GT1.1 immunizations in infant
macaques over time through i) the quantification of the functional activity, avidity and target epitope of polyclonal
plasma antibody responses (Aim 1) and ii) single cell RNA sequencing of antigen-specific B cell analysis (Aim
2) to evaluate the evolution of vaccine-elicited HIV bNAb precursors and relate these responses to innate
immunity (Project 1) and microbial interactions (Project 2). To accomplish this goal, the B Cell Core will draw
on the extensive experience and unique resources in antibody and B cell response characterization of the B Cell
Core Leader Dr. Marit van Gils at Amsterdam UMC and Dr. Sallie Permar at Weill Cornell Medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative Core
-
批准号:10731277
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2023
-
负责人:Kristina De Paris
-
依托单位:
Project 1: The impact of innate immune responses on the development of broadly neutralizing antibodies by vaccination
-
批准号:10731281
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2023
-
负责人:Kristina De Paris
-
依托单位:
Project 2: Microbial determinants of HIV broadly-neutralizing antibody precursor induction in infants
-
批准号:10731282
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2023
-
负责人:Kristina De Paris
-
依托单位:
Core B: Non-human Primate Core
-
批准号:10731278
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2023
-
负责人:Kristina De Paris
-
依托单位:
Determinants of HIV broadly-neutralizing antibody precursor induction in infants
-
批准号:10731276
-
项目类别:
-
资助金额:$158.46万
-
财政年份:2023
-
负责人:Kristina De Paris
-
依托单位:
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
-
批准号:10593523
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2023
-
负责人:Kristina De Paris
-
依托单位:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
-
批准号:10223634
-
项目类别:
-
资助金额:$20.34万
-
财政年份:2020
-
负责人:Kristina De Paris
-
依托单位:
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
-
批准号:10172886
-
项目类别:
-
资助金额:$92.08万
-
财政年份:2018
-
负责人:Kristina De Paris
-
依托单位:
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
-
批准号:10425465
-
项目类别:
-
资助金额:$91.17万
-
财政年份:2018
-
负责人:Kristina De Paris
-
依托单位:
The Pros and Cons of Trained Immunity Induced by Vaccines for Tuberculosis Prevention
-
批准号:9207318
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2016
-
负责人:Kristina De Paris
-
依托单位:
The Pros and Cons of Trained Immunity Induced by Vaccines for Tuberculosis Prevention
-
批准号:9310395
-
项目类别:
-
资助金额:$22.8万
-
财政年份:2016
-
负责人:Kristina De Paris
-
依托单位:
Early Life Vaccination to Prevent HIV acquisition during Adolescence
-
批准号:10602513
-
项目类别:
-
资助金额:$138.17万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Core-002
-
批准号:10822793
-
项目类别:
-
资助金额:$54.19万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
-
批准号:10370482
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Admin-Core-002
-
批准号:10822792
-
项目类别:
-
资助金额:$13.8万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Early Life Vaccination to Prevent HIV acquisition during Adolescence
-
批准号:10324885
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Early Life Vaccination to Prevent HIV acquisition during Adolescence
-
批准号:9893368
-
项目类别:
-
资助金额:$130.78万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Early Life Vaccination to Prevent HIV acquisition during Adolescence
-
批准号:10379073
-
项目类别:
-
资助金额:$137.59万
-
财政年份:2015
-
负责人:Kristina De Paris
-
依托单位:
Molecular Mechanisms Associated with Immune Maturation in Infants
-
批准号:8708750
-
项目类别:
-
资助金额:$40.85万
-
财政年份:2012
-
负责人:Kristina De Paris
-
依托单位:
Molecular Mechanisms Associated with Immune Maturation in Infants
-
批准号:8533837
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2012
-
负责人:Kristina De Paris
-
依托单位:
海外基金